Evidence map›Paper›PMID 42578160›Full record

ArticleAPL bioengineering2026

Construction of 3D bioprinted colorectal cancer models and evaluation of their efficacy and drug sensitivity.

Feng Tong, Ruijin Nie, Zhenyu Wu, Longfei Zhang, Xia Zhang, Xiaoyu Duan, Qi Zhang, Wen Tang

Abstract read
In one paragraph

Article in APL bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Feng TongDepartment of General Surgery, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.ORCID https://orcid.org/0009-0005-5276-8761
Ruijin NieDepartment of General Surgery, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Zhenyu WuDepartment of Pathology, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Longfei ZhangDepartment of General Surgery, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Xia ZhangDepartment of Endocrinology, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Xiaoyu DuanDepartment of General Surgery, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Qi ZhangDepartment of General Surgery, Lanxi People's Hospital, Lanxi 321100, Zhejiang, China.
Wen TangSaibo (Shanghai) Intelligent Technology Co., Ltd., Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, preclinical research on colorectal cancer (CRC) lacks effective tumor models. In recent years, 3D bioprinted models have shown great potential in tumor model construction. This study used 3D bioprinting technology to establish a CRC extracellular matrix (ECM) model. Gradient concentrations of laminin/entactin complex combined with photocurable gelatin methacrylate (GelMA) hydrogel were used to prepare 3D bioprinting bioinks with biomimetic ECM properties. Biocompatibility was assessed by calcein-AM and propidium iodide staining. Proliferation was evaluated using the CellTiter-Glo

Identifiers

PMID42578160
PMCPMC13456972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.